{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:42:26Z","timestamp":1792075346986,"version":"4.4.0"},"reference-count":270,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T00:00:00Z","timestamp":1635465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T00:00:00Z","timestamp":1635465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1038\/s41584-021-00709-9","type":"journal-article","created":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T09:06:27Z","timestamp":1635498387000},"page":"731-748","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":223,"title":["Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3085-9521","authenticated-orcid":false,"given":"Chetan","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6083-4355","authenticated-orcid":false,"given":"Madhusudan","family":"Ganigara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Galeotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando M.","family":"Berganza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise A.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davinder","family":"Singh-Grewal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suman","family":"Bharath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujata","family":"Sajjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0498-9808","authenticated-orcid":false,"given":"Jagadeesh","family":"Bayry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,29]]},"reference":[{"key":"709_CR1","doi-asserted-by":"crossref","first-page":"105946","DOI":"10.1016\/j.ijantimicag.2020.105946","volume":"55","author":"C-C Lai","year":"2020","unstructured":"Lai, C.-C. et al. Global epidemiology of coronavirus disease 2019 (COVID-19): disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status. Int. J. Antimicrob. Agents 55, 105946 (2020).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"709_CR2","first-page":"157","volume":"91","author":"D Cucinotta","year":"2020","unstructured":"Cucinotta, D. & Vanelli, M. WHO declares COVID-19 a pandemic. Acta Bio Med. Atenei Parm. 91, 157\u2013160 (2020).","journal-title":"Acta Bio Med. Atenei Parm."},{"key":"709_CR3","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1016\/j.jacc.2020.04.031","volume":"75","author":"B Bikdeli","year":"2020","unstructured":"Bikdeli, B. et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J. Am. Coll. Cardiol. 75, 2950\u20132973 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"709_CR4","doi-asserted-by":"crossref","first-page":"105921","DOI":"10.1016\/j.clineuro.2020.105921","volume":"194","author":"V Montalvan","year":"2020","unstructured":"Montalvan, V., Lee, J., Bueso, T., De Toledo, J. & Rivas, K. Neurological manifestations of COVID-19 and other coronavirus infections: a systematic review. Clin. Neurol. Neurosurg. 194, 105921 (2020).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"709_CR5","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1161\/CIRCULATIONAHA.120.046941","volume":"141","author":"KJ Clerkin","year":"2020","unstructured":"Clerkin, K. J. et al. COVID-19 and cardiovascular disease. Circulation 141, 1648\u20131655 (2020).","journal-title":"Circulation"},{"key":"709_CR6","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/S0735-1097(02)01886-7","volume":"39","author":"JIE Hoffman","year":"2002","unstructured":"Hoffman, J. I. E. & Kaplan, S. The incidence of congenital heart disease. J. Am. Coll. Cardiol. 39, 1890\u20131900 (2002).","journal-title":"J. Am. Coll. Cardiol."},{"key":"709_CR7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cytogfr.2020.05.003","volume":"53","author":"F Coperchini","year":"2020","unstructured":"Coperchini, F., Chiovato, L., Croce, L., Magri, F. & Rotondi, M. The cytokine storm in COVID-19: an overview of the involvement of the chemokine\/chemokine-receptor system. Cytokine Growth Factor. Rev. 53, 25\u201332 (2020).","journal-title":"Cytokine Growth Factor. Rev."},{"key":"709_CR8","volume":"11","author":"X Ou","year":"2020","unstructured":"Ou, X. et al. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat. Commun. 11, 1620 (2020).","journal-title":"Nat. Commun."},{"key":"709_CR9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and Is blocked by a clinically proven protease inhibitor. Cell 181, 271\u2013280.e8 (2020).","journal-title":"Cell"},{"key":"709_CR10","doi-asserted-by":"crossref","first-page":"102763","DOI":"10.1016\/j.ebiom.2020.102763","volume":"55","author":"J Liu","year":"2020","unstructured":"Liu, J. et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine 55, 102763 (2020).","journal-title":"EBioMedicine"},{"key":"709_CR11","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0140-6736(20)31103-X","volume":"395","author":"L Verdoni","year":"2020","unstructured":"Verdoni, L. et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet 395, 1771\u20131778 (2020). An early report of MIS-C from the first wave of COVID-19 in mid-2020.","journal-title":"Lancet"},{"key":"709_CR12","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(20)31094-1","volume":"395","author":"S Riphagen","year":"2020","unstructured":"Riphagen, S., Gomez, X., Gonzalez-Martinez, C., Wilkinson, N. & Theocharis, P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet 395, 1607\u20131608 (2020). An early report of MIS-C from the first wave of COVID-19 in mid-2020.","journal-title":"Lancet"},{"key":"709_CR13","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1056\/NEJMoa2021680","volume":"383","author":"LR Feldstein","year":"2020","unstructured":"Feldstein, L. R. et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N. Engl. J. Med. 383, 334\u2013346 (2020). An early report of MIS-C from the first wave of COVID-19 in mid-2020.","journal-title":"N. Engl. J. Med."},{"key":"709_CR14","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa2021756","volume":"383","author":"EM Dufort","year":"2020","unstructured":"Dufort, E. M. et al. Multisystem inflammatory syndrome in children in New York State. N. Engl. J. Med. 383, 347\u2013358 (2020). An early report of MIS-C from the first wave of COVID-19 in mid-2020.","journal-title":"N. Engl. J. Med."},{"key":"709_CR15","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1001\/jama.2020.10374","volume":"324","author":"EW Cheung","year":"2020","unstructured":"Cheung, E. W. et al. Multisystem inflammatory syndrome related to COVID-19 in previously healthy children and adolescents in New York City. JAMA 324, 294\u2013296 (2020). An early report of MIS-C from the first wave of COVID-19 in mid-2020.","journal-title":"JAMA"},{"key":"709_CR16","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41584-020-0448-7","volume":"16","author":"C Galeotti","year":"2020","unstructured":"Galeotti, C. & Bayry, J. Autoimmune and inflammatory diseases following COVID-19. Nat. Rev. Rheumatol. 16, 413\u2013414 (2020).","journal-title":"Nat. Rev. Rheumatol."},{"key":"709_CR17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/CIRCULATIONAHA.120.048726","volume":"142","author":"JM Simpson","year":"2020","unstructured":"Simpson, J. M. & Newburger, J. W. Multi-system inflammatory syndrome in children in association with COVID-19. Circulation 142, 437\u2013440 (2020).","journal-title":"Circulation"},{"key":"709_CR18","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMe2023158","volume":"383","author":"M Levin","year":"2020","unstructured":"Levin, M. Childhood multisystem inflammatory syndrome \u2014 a new challenge in the pandemic. N. Engl. J. Med. 383, 393\u2013395 (2020).","journal-title":"N. Engl. J. Med."},{"key":"709_CR19","first-page":"178","volume":"16","author":"T Kawasaki","year":"1967","unstructured":"Kawasaki, T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi 16, 178\u2013222 (1967).","journal-title":"Arerugi"},{"key":"709_CR20","first-page":"e927","volume":"135","author":"W McCrindle Brian","year":"2017","unstructured":"McCrindle Brian, W. et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 135, e927\u2013e999 (2017).","journal-title":"Circulation"},{"key":"709_CR21","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1086\/430953","volume":"192","author":"JC Burns","year":"2005","unstructured":"Burns, J. C. et al. Genetic variations in the receptor-ligand pair CCR5 and CCL3L1 are important determinants of susceptibility to Kawasaki disease. J. Infect. Dis. 192, 344\u2013349 (2005).","journal-title":"J. Infect. Dis."},{"key":"709_CR22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000319","volume":"5","author":"D Burgner","year":"2009","unstructured":"Burgner, D. et al. A genome-wide association study identifies novel and functionally related susceptibility loci for Kawasaki disease. PLoS Genet. 5, e1000319 (2009).","journal-title":"PLoS Genet."},{"key":"709_CR23","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijid.2005.03.002","volume":"9","author":"D Burgner","year":"2005","unstructured":"Burgner, D. & Harnden, A. Kawasaki disease: what is the epidemiology telling us about the etiology? Int. J. Infect. Dis. 9, 185\u2013194 (2005).","journal-title":"Int. J. Infect. Dis."},{"key":"709_CR24","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1542\/pir.2016-0182","volume":"39","author":"MBF Son","year":"2018","unstructured":"Son, M. B. F. & Newburger, J. W. Kawasaki disease. Pediatr. Rev. 39, 78\u201390 (2018).","journal-title":"Pediatr. Rev."},{"key":"709_CR25","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1056\/NEJMp068268","volume":"356","author":"JC Burns","year":"2007","unstructured":"Burns, J. C. The riddle of Kawasaki disease. N. Engl. J. Med. 356, 659\u2013661 (2007).","journal-title":"N. Engl. J. Med."},{"key":"709_CR26","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1542\/peds.112.3.495","volume":"112","author":"RC Holman","year":"2003","unstructured":"Holman, R. C., Curns, A. T., Belay, E. D., Steiner, C. A. & Schonberger, L. B. Kawasaki syndrome hospitalizations in the United States, 1997 and 2000. Pediatrics 112, 495\u2013501 (2003).","journal-title":"Pediatrics"},{"key":"709_CR27","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1086\/315111","volume":"180","author":"TW Kuijpers","year":"1999","unstructured":"Kuijpers, T. W. et al. Kawasaki disease: a maturational defect in immune responsiveness. J. Infect. Dis. 180, 1869\u20131877 (1999).","journal-title":"J. Infect. Dis."},{"key":"709_CR28","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/ije\/21.2.381","volume":"21","author":"MS Green","year":"1992","unstructured":"Green, M. S. The male predominance in the incidence of infectious diseases in children: a postulated explanation for disparities in the literature. Int. J. Epidemiol. 21, 381\u2013386 (1992).","journal-title":"Int. J. Epidemiol."},{"key":"709_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006454-200301000-00002","volume":"22","author":"D Burgner","year":"2003","unstructured":"Burgner, D. & Levin, M. Genetic susceptibility to infectious diseases. Pediatr. Infect. Dis. J. 22, 1\u20136 (2003).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"709_CR30","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1136\/bmj.324.7351.1424","volume":"324","author":"A Harnden","year":"2002","unstructured":"Harnden, A., Alves, B. & Sheikh, A. Rising incidence of Kawasaki disease in England: analysis of hospital admission data. BMJ 324, 1424\u20131425 (2002).","journal-title":"BMJ"},{"key":"709_CR31","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1001\/archpedi.1983.02140290003001","volume":"137","author":"DM Bell","year":"1983","unstructured":"Bell, D. M., Morens, D. M., Holman, R. C., Hurwitz, E. S. & Hunter, M. K. Kawasaki syndrome in the United States 1976 to 1980. Am. J. Dis. Child. 137, 211\u2013214 (1983).","journal-title":"Am. J. Dis. Child."},{"key":"709_CR32","volume":"109","author":"R-KR Chang","year":"2002","unstructured":"Chang, R.-K. R. Hospitalizations for Kawasaki disease among children in the United States, 1988\u20131997. Pediatrics 109, e87 (2002).","journal-title":"Pediatrics"},{"key":"709_CR33","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00006454-200202000-00004","volume":"21","author":"Z-D Du","year":"2002","unstructured":"Du, Z.-D. et al. Epidemiologic picture of Kawasaki disease in Beijing from 1995 through 1999. Pediatr. Infect. Dis. J. 21, 103\u2013107 (2002).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"709_CR34","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3346\/jkms.2002.17.4.453","volume":"17","author":"Y-W Park","year":"2002","unstructured":"Park, Y.-W. et al. Epidemiologic study of Kawasaki disease in Korea, 1997-1999: comparison with previous studies during 1991-1996. J. Korean Med. Sci. 17, 453\u2013456 (2002).","journal-title":"J. Korean Med. Sci."},{"key":"709_CR35","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2188\/jea.JE20110131","volume":"22","author":"R Uehara","year":"2012","unstructured":"Uehara, R. & Belay, E. D. Epidemiology of Kawasaki disease in Asia, Europe, and the United States. J. Epidemiol. 22, 79\u201385 (2012).","journal-title":"J. Epidemiol."},{"key":"709_CR36","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1001\/archpedi.1995.02170200069011","volume":"149","author":"H Yanagawa","year":"1995","unstructured":"Yanagawa, H., Yashiro, M., Nakamura, Y., Kawasaki, T. & Kato, H. Results of 12 nationwide epidemiological incidence surveys of Kawasaki disease in Japan. Arch. Pediatr. Adolesc. Med. 149, 779\u2013783 (1995).","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"709_CR37","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/01.ede.0000152901.06689.d4","volume":"16","author":"JC Burns","year":"2005","unstructured":"Burns, J. C. et al. Seasonality and temporal clustering of Kawasaki syndrome. Epidemiology 16, 220\u2013225 (2005).","journal-title":"Epidemiology"},{"key":"709_CR38","first-page":"19","volume":"250","author":"Y Nakamura","year":"1987","unstructured":"Nakamura, Y., Yanagawa, I. & Kawasaki, T. Temporal and geographical clustering of Kawasaki disease in Japan. Prog. Clin. Biol. Res. 250, 19\u201332 (1987).","journal-title":"Prog. Clin. Biol. Res."},{"key":"709_CR39","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S0140-6736(86)90541-6","volume":"2","author":"H Yanagawa","year":"1986","unstructured":"Yanagawa, H., Nakamura, Y., Kawasaki, T. & Shigematsu, I. Nationwide epidemic of Kawasaki disease in Japan during winter of 1985-86. Lancet 2, 1138\u20131139 (1986).","journal-title":"Lancet"},{"key":"709_CR40","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jfma.2013.12.008","volume":"113","author":"L-Y Chang","year":"2014","unstructured":"Chang, L.-Y. et al. Viral infections associated with Kawasaki disease. J. Formos. Med. Assoc. 113, 148\u2013154 (2014).","journal-title":"J. Formos. Med. Assoc."},{"key":"709_CR41","doi-asserted-by":"crossref","first-page":"e760","DOI":"10.1542\/peds.2005-0559","volume":"116","author":"SM Benseler","year":"2005","unstructured":"Benseler, S. M. et al. Infections and Kawasaki disease: implications for coronary artery outcome. Pediatrics 116, e760\u2013e766 (2005).","journal-title":"Pediatrics"},{"key":"709_CR42","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1086\/428291","volume":"191","author":"F Esper","year":"2005","unstructured":"Esper, F. et al. Association between a novel human coronavirus and Kawasaki disease. J. Infect. Dis. 191, 499\u2013502 (2005).","journal-title":"J. Infect. Dis."},{"key":"709_CR43","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1086\/422648","volume":"190","author":"AH Rowley","year":"2004","unstructured":"Rowley, A. H. et al. Detection of antigen in bronchial epithelium and macrophages in acute Kawasaki disease by use of synthetic antibody. J. Infect. Dis. 190, 856\u2013865 (2004).","journal-title":"J. Infect. Dis."},{"key":"709_CR44","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/jamapediatrics.2016.1446","volume":"170","author":"E Cohen","year":"2016","unstructured":"Cohen, E. & Sundel, R. Kawasaki disease at 50 years. JAMA Pediatr. 170, 1093\u20131099 (2016).","journal-title":"JAMA Pediatr."},{"key":"709_CR45","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/1756-185X.13213","volume":"21","author":"AH Rowley","year":"2018","unstructured":"Rowley, A. H. Is Kawasaki disease an infectious disorder? Int. J. Rheum. Dis. 21, 20\u201325 (2018).","journal-title":"Int. J. Rheum. Dis."},{"key":"709_CR46","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1073\/pnas.89.9.4066","volume":"89","author":"J Abe","year":"1992","unstructured":"Abe, J. et al. Selective expansion of T cells expressing T-cell receptor variable regions V\u03b22 and V\u03b2 8 in Kawasaki disease. Proc. Natl Acad. Sci. USA 89, 4066\u20134070 (1992).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"709_CR47","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1084\/jem.177.3.791","volume":"177","author":"J Abe","year":"1993","unstructured":"Abe, J. et al. Characterization of T cell repertoire changes in acute Kawasaki disease. J. Exp. Med. 177, 791\u2013796 (1993).","journal-title":"J. Exp. Med."},{"key":"709_CR48","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1136\/adc.72.4.308","volume":"72","author":"N Curtis","year":"1995","unstructured":"Curtis, N., Zheng, R., Lamb, J. R. & Levin, M. Evidence for a superantigen mediated process in Kawasaki disease. Arch. Dis. Child. 72, 308\u2013311 (1995).","journal-title":"Arch. Dis. Child."},{"key":"709_CR49","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1365-2567.2009.03135.x","volume":"128","author":"S Nagata","year":"2009","unstructured":"Nagata, S. et al. Heat shock proteins and superantigenic properties of bacteria from the gastrointestinal tract of patients with Kawasaki disease. Immunology 128, 511\u2013520 (2009).","journal-title":"Immunology"},{"key":"709_CR50","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.4049\/jimmunol.153.4.1881","volume":"153","author":"BA Pietra","year":"1994","unstructured":"Pietra, B. A., Inocencio, J. D., Giannini, E. H. & Hirsch, R. TCR V\u03b2 family repertoire and T cell activation markers in Kawasaki disease. J. Immunol. 153, 1881\u20131888 (1994).","journal-title":"J. Immunol."},{"key":"709_CR51","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1046\/j.1365-3083.1998.00415.x","volume":"48","author":"L Mancia","year":"1998","unstructured":"Mancia, L. et al. Characterization of the T-cell receptor V-\u03b2 repertoire in Kawasaki disease. Scand. J. Immunol. 48, 443\u2013449 (1998).","journal-title":"Scand. J. Immunol."},{"key":"709_CR52","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3345\/kjp.2017.60.7.216","volume":"60","author":"JS Jun","year":"2017","unstructured":"Jun, J. S., Jung, Y. K. & Lee, D. W. Relationship between vitamin D levels and intravenous immunoglobulin resistance in Kawasaki disease. Korean J. Pediatr. 60, 216\u2013220 (2017).","journal-title":"Korean J. Pediatr."},{"key":"709_CR53","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1530\/eje.0.1450351","volume":"145","author":"MO Canning","year":"2001","unstructured":"Canning, M. O., Grotenhuis, K., de Wit, H., Ruwhof, C. & Drexhage, H. A. 1-\u03b1,25-Dihydroxyvitamin D3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes. Eur. J. Endocrinol. 145, 351\u2013357 (2001).","journal-title":"Eur. J. Endocrinol."},{"key":"709_CR54","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1158\/1535-7163.MCT-06-0677","volume":"6","author":"M Ben-Shoshan","year":"2007","unstructured":"Ben-Shoshan, M. et al. 1\u03b1,25-dihydroxyvitamin D3 (Calcitriol) inhibits hypoxia-inducible factor-1\/vascular endothelial growth factor pathway in human cancer cells. Mol. Cancer Ther. 6, 1433\u20131439 (2007).","journal-title":"Mol. Cancer Ther."},{"key":"709_CR55","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12887-019-1438-2","volume":"19","author":"K Meyer","year":"2019","unstructured":"Meyer, K. et al. Breastfeeding and vitamin D supplementation reduce the risk of Kawasaki disease in a German population-based case-control study. BMC Pediatr. 19, 66 (2019).","journal-title":"BMC Pediatr."},{"key":"709_CR56","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s10067-015-2970-6","volume":"35","author":"S Stagi","year":"2016","unstructured":"Stagi, S., Rigante, D., Lepri, G., Matucci Cerinic, M. & Falcini, F. Severe vitamin D deficiency in patients with Kawasaki disease: a potential role in the risk to develop heart vascular abnormalities? Clin. Rheumatol. 35, 1865\u20131872 (2016).","journal-title":"Clin. Rheumatol."},{"key":"709_CR57","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s00431-014-2346-y","volume":"173","author":"Y-L Chen","year":"2014","unstructured":"Chen, Y.-L., Wang, J.-L. & Li, W.-Q. Prediction of the risk of coronary arterial lesions in Kawasaki disease by serum 25-hydroxyvitamin D3. Eur. J. Pediatr. 173, 1467\u20131471 (2014).","journal-title":"Eur. J. Pediatr."},{"key":"709_CR58","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3345\/kjp.2018.06905","volume":"62","author":"S Kim","year":"2019","unstructured":"Kim, S. & Eun, L. Y. Iron deficiency anemia as a predictor of coronary artery abnormalities in Kawasaki disease. Korean J. Pediatr. 62, 301\u2013306 (2019).","journal-title":"Korean J. Pediatr."},{"key":"709_CR59","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cell.2014.03.011","volume":"157","author":"Y Belkaid","year":"2014","unstructured":"Belkaid, Y. & Hand, T. Role of the microbiota in immunity and inflammation. Cell 157, 121\u2013141 (2014).","journal-title":"Cell"},{"key":"709_CR60","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.3389\/fimmu.2020.01616","volume":"11","author":"K Kaneko","year":"2020","unstructured":"Kaneko, K., Akagawa, S., Akagawa, Y., Kimata, T. & Tsuji, S. Our evolving understanding of Kawasaki disease pathogenesis: role of the gut microbiota. Front. Immunol. 11, 1616 (2020).","journal-title":"Front. Immunol."},{"key":"709_CR61","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1203\/00006450-199604000-00010","volume":"39","author":"Y Yamashiro","year":"1996","unstructured":"Yamashiro, Y., Nagata, S., Ohtsuka, Y., Oguchi, S. & Shimizu, T. Microbiologic studies on the small intestine in Kawasaki disease. Pediatr. Res. 39, 622\u2013624 (1996).","journal-title":"Pediatr. Res."},{"key":"709_CR62","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1651-2227.2002.tb03327.x","volume":"91","author":"S Takeshita","year":"2002","unstructured":"Takeshita, S., Kobayashi, I., Kawamura, Y., Tokutomi, T. & Sekine, I. Characteristic profile of intestinal microflora in Kawasaki disease. Acta Paediatr. 91, 783\u2013788 (2002).","journal-title":"Acta Paediatr."},{"key":"709_CR63","volume":"10","author":"J Chen","year":"2020","unstructured":"Chen, J. et al. Altered gut microbiota correlated with systemic inflammation in children with Kawasaki disease. Sci. Rep. 10, 14525 (2020).","journal-title":"Sci. Rep."},{"key":"709_CR64","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s12016-020-08783-9","volume":"59","author":"R Kumrah","year":"2020","unstructured":"Kumrah, R., Vignesh, P., Rawat, A. & Singh, S. Immunogenetics of Kawasaki disease. Clin. Rev. Allergy Immunol. 59, 122\u2013139 (2020).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"709_CR65","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/01.inf.0000160946.05295.91","volume":"24","author":"RC Holman","year":"2005","unstructured":"Holman, R. C. et al. Kawasaki syndrome in Hawaii. Pediatr. Infect. Dis. J. 24, 429\u2013433 (2005).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"709_CR66","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1542\/peds.84.4.666","volume":"84","author":"Y Fujita","year":"1989","unstructured":"Fujita, Y. et al. Kawasaki disease in families. Pediatrics 84, 666\u2013669 (1989).","journal-title":"Pediatrics"},{"key":"709_CR67","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1093\/hmg\/ddq176","volume":"19","author":"Y Onouchi","year":"2010","unstructured":"Onouchi, Y. et al. Common variants in CASP3 confer susceptibility to Kawasaki disease. Hum. Mol. Genet. 19, 2898\u20132906 (2010). The results of this study indicate that multiple variants in the caspase 3 gene (CASP3) confer susceptibility to Kawasaki disease.","journal-title":"Hum. Mol. Genet."},{"key":"709_CR68","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/CIRCGENETICS.110.940858","volume":"4","author":"C Shimizu","year":"2011","unstructured":"Shimizu, C. et al. Transforming growth factor-beta signaling pathway in patients with Kawasaki disease. Circ. Cardiovasc. Genet. 4, 16\u201325 (2011).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"709_CR69","doi-asserted-by":"crossref","first-page":"697632","DOI":"10.3389\/fped.2021.697632","volume":"9","author":"L Chang","year":"2021","unstructured":"Chang, L., Yang, H.-W., Lin, T.-Y. & Yang, K. D. Perspective of immunopathogenesis and immunotherapies for Kawasaki disease. Front. Pediatr. 9, 697632 (2021).","journal-title":"Front. Pediatr."},{"key":"709_CR70","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.4049\/jimmunol.1600388","volume":"197","author":"MP Alphonse","year":"2016","unstructured":"Alphonse, M. P. et al. Inositol-triphosphate 3-kinase c mediates inflammasome activation and treatment response in Kawasaki disease. J. Immunol. 197, 3481\u20133489 (2016).","journal-title":"J. Immunol."},{"key":"709_CR71","doi-asserted-by":"crossref","first-page":"46R","DOI":"10.1203\/PDR.0b013e31819dba60","volume":"65","author":"Y Onouchi","year":"2009","unstructured":"Onouchi, Y. Molecular genetics of Kawasaki disease. Pediatr. Res. 65, 46R\u201354R (2009).","journal-title":"Pediatr. Res."},{"key":"709_CR72","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jpeds.2019.04.044","volume":"210","author":"JC Burns","year":"2019","unstructured":"Burns, J. C. Cyclosporine and coronary outcomes in Kawasaki disease. J. Pediatr. 210, 239\u2013242 (2019).","journal-title":"J. Pediatr."},{"key":"709_CR73","first-page":"1417","volume":"131","author":"I Matsuda","year":"1977","unstructured":"Matsuda, I., Hattori, S., Nagata, N., Fruse, A. & Nambu, H. HLA antigens in mucocutaneous lymph node syndrome. Am. J. Dis. Child 131, 1417\u20131418 (1977).","journal-title":"Am. J. Dis. Child"},{"key":"709_CR74","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1542\/peds.61.2.252","volume":"61","author":"S Kato","year":"1978","unstructured":"Kato, S. et al. HLA antigens in Kawasaki disease. Pediatrics 61, 252\u2013255 (1978).","journal-title":"Pediatrics"},{"key":"709_CR75","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1542\/peds.67.5.741","volume":"67","author":"AM Krensky","year":"1981","unstructured":"Krensky, A. M., Berenberg, W., Shanley, K. & Yunis, E. J. HLA antigens in mucocutaneous lymph node syndrome in New England. Pediatrics 67, 741\u2013743 (1981).","journal-title":"Pediatrics"},{"key":"709_CR76","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3389\/fped.2021.673294","volume":"9","author":"K Sharma","year":"2021","unstructured":"Sharma, K. et al. Epigenetics in Kawasaki disease. Front. Pediatr. 9, 626 (2021).","journal-title":"Front. Pediatr."},{"key":"709_CR77","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/1756-185X.12911","volume":"21","author":"R Assari","year":"2018","unstructured":"Assari, R. et al. Pro-inflammatory cytokine single nucleotide polymorphisms in Kawasaki disease. Int. J. Rheum. Dis. 21, 1120\u20131126 (2018).","journal-title":"Int. J. Rheum. Dis."},{"key":"709_CR78","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1253\/circj.CJ-09-0664","volume":"74","author":"K-P Weng","year":"2010","unstructured":"Weng, K.-P. et al. IL-1B polymorphism in association with initial intravenous immunoglobulin treatment failure in Taiwanese children with Kawasaki disease. Circ. J. 74, 544\u2013551 (2010).","journal-title":"Circ. J."},{"key":"709_CR79","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/jhg.2013.43","volume":"58","author":"J-J Kim","year":"2013","unstructured":"Kim, J.-J. et al. Identification of KCNN2 as a susceptibility locus for coronary artery aneurysms in Kawasaki disease using genome-wide association analysis. J. Hum. Genet. 58, 521\u2013525 (2013).","journal-title":"J. Hum. Genet."},{"key":"709_CR80","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00246-018-1992-7","volume":"40","author":"Y-C Kwon","year":"2019","unstructured":"Kwon, Y.-C. et al. Identification of the TIFAB gene as a susceptibility locus for coronary artery aneurysm in patients with Kawasaki disease. Pediatr. Cardiol. 40, 483\u2013488 (2019).","journal-title":"Pediatr. Cardiol."},{"key":"709_CR81","volume":"21","author":"Z Lu","year":"2019","unstructured":"Lu, Z. et al. P2RY12:rs7637803 TT variant genotype increases coronary artery aneurysm risk in Kawasaki disease in a southern Chinese population. J. Gene Med. 21, e3066 (2019).","journal-title":"J. Gene Med."},{"key":"709_CR82","first-page":"4730507","volume":"2019","author":"LY Fu","year":"2019","unstructured":"Fu, L. Y. et al. The IL-1B gene polymorphisms rs16944 and rs1143627 contribute to an increased risk of coronary artery lesions in southern Chinese children with Kawasaki disease. J. Immunol. Res. 2019, 4730507 (2019).","journal-title":"J. Immunol. Res."},{"key":"709_CR83","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/cei.12832","volume":"186","author":"T Hara","year":"2016","unstructured":"Hara, T. et al. Kawasaki disease: a matter of innate immunity. Clin. Exp. Immunol. 186, 134\u2013143 (2016).","journal-title":"Clin. Exp. Immunol."},{"key":"709_CR84","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3345\/kjp.2017.60.4.112","volume":"60","author":"NH Lee","year":"2017","unstructured":"Lee, N. H., Choi, H. J. & Kim, Y. H. Clinical usefulness of serum procalcitonin level in distinguishing between Kawasaki disease and other infections in febrile children. Korean J. Pediatr. 60, 112\u2013117 (2017).","journal-title":"Korean J. Pediatr."},{"key":"709_CR85","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/INF.0b013e31821e52c6","volume":"30","author":"AH Tremoulet","year":"2011","unstructured":"Tremoulet, A. H. et al. Increased incidence and severity of Kawasaki disease among Filipino-Americans in San Diego county. Pediatr. Infect. Dis. J. 30, 909\u2013911 (2011).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"709_CR86","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(04)16814-1","volume":"364","author":"JC Burns","year":"2004","unstructured":"Burns, J. C. & Glod\u00e9, M. P. Kawasaki syndrome. Lancet 364, 533\u2013544 (2004).","journal-title":"Lancet"},{"key":"709_CR87","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1365-2249.2009.04073.x","volume":"160","author":"K Ikeda","year":"2010","unstructured":"Ikeda, K. et al. Unique activation status of peripheral blood mononuclear cells at acute phase of Kawasaki disease. Clin. Exp. Immunol. 160, 246\u2013255 (2010).","journal-title":"Clin. Exp. Immunol."},{"key":"709_CR88","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/art.40784","volume":"71","author":"G Armaroli","year":"2019","unstructured":"Armaroli, G. et al. Monocyte-derived interleukin-1\u03b2 as the driver of S100A12-induced sterile inflammatory activation of human coronary artery endothelial cells: implications for the pathogenesis of Kawasaki disease. Arthritis Rheumatol. 71, 792\u2013804 (2019). This article provides mechanistic insight on the roles of S100A12 and IL-1\u03b2 in the pathogenesis of Kawasaki disease, and supports the therapeutic use of IL-1\u03b2 inhibitors.","journal-title":"Arthritis Rheumatol."},{"key":"709_CR89","doi-asserted-by":"crossref","first-page":"205873921876094","DOI":"10.1177\/2058739218760946","volume":"16","author":"K Zhang","year":"2018","unstructured":"Zhang, K. et al. Increase in T helper type 17 cells in children with Kawasaki disease is NR4A2 dependent. Eur. J. Inflamm. 16, 2058739218760945 (2018).","journal-title":"Eur. J. Inflamm."},{"key":"709_CR90","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10238-018-00544-5","volume":"19","author":"Y Wu","year":"2019","unstructured":"Wu, Y. et al. Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm. Clin. Exp. Med. 19, 173\u2013181 (2019).","journal-title":"Clin. Exp. Med."},{"key":"709_CR91","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3109\/14397595.2013.854061","volume":"24","author":"T Oharaseki","year":"2014","unstructured":"Oharaseki, T. et al. The role of TNF-\u03b1 in a murine model of Kawasaki disease arteritis induced with a Candida albicans cell wall polysaccharide. Mod. Rheumatol. 24, 120\u2013128 (2014).","journal-title":"Mod. Rheumatol."},{"key":"709_CR92","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0022-3476(05)80343-9","volume":"121","author":"CY Lin","year":"1992","unstructured":"Lin, C. Y., Lin, C. C., Hwang, B. & Chiang, B. Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease. J. Pediatr. 121, 924\u2013926 (1992).","journal-title":"J. Pediatr."},{"key":"709_CR93","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/all.12558","volume":"70","author":"MM-H Guo","year":"2015","unstructured":"Guo, M. M.-H. et al. Th17- and Treg-related cytokine and mRNA expression are associated with acute and resolving Kawasaki disease. Allergy 70, 310\u2013318 (2015).","journal-title":"Allergy"},{"key":"709_CR94","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF01956740","volume":"152","author":"C-Y Lin","year":"1993","unstructured":"Lin, C.-Y., Lin, C.-C., Hwang, B. & Chiang, B. N. Cytokines predict coronary aneurysm formation in Kawasaki disease patients. Eur. J. Pediatr. 152, 309\u2013312 (1993).","journal-title":"Eur. J. Pediatr."},{"key":"709_CR95","first-page":"325","volume":"11","author":"F Rahmani","year":"2019","unstructured":"Rahmani, F. et al. Interleukin 10 and and transforming growth factor \u03b2 polymorphisms as risk factors for Kawasaki disease: a case-control study and meta-analysis. Avicenna J. Med. Biotechnol. 11, 325\u2013333 (2019).","journal-title":"Avicenna J. Med. Biotechnol."},{"key":"709_CR96","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2249.2010.04236.x","volume":"162","author":"S Jia","year":"2010","unstructured":"Jia, S., Li, C., Wang, G., Yang, J. & Zu, Y. The T helper type 17\/regulatory T cell imbalance in patients with acute Kawasaki disease. Clin. Exp. Immunol. 162, 131\u2013137 (2010).","journal-title":"Clin. Exp. Immunol."},{"key":"709_CR97","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/s41390-019-0710-3","volume":"87","author":"Y Yoshida","year":"2020","unstructured":"Yoshida, Y. et al. Enhanced formation of neutrophil extracellular traps in Kawasaki disease. Pediatr. Res. 87, 998\u20131004 (2020).","journal-title":"Pediatr. Res."},{"key":"709_CR98","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/nri.2017.105","volume":"18","author":"V Papayannopoulos","year":"2018","unstructured":"Papayannopoulos, V. Neutrophil extracellular traps in immunity and disease. Nat. Rev. Immunol. 18, 134\u2013147 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"709_CR99","first-page":"73ra20","volume":"3","author":"GS Garcia-Romo","year":"2011","unstructured":"Garcia-Romo, G. S. et al. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci. Transl. Med. 3, 73ra20 (2011).","journal-title":"Sci. Transl. Med."},{"key":"709_CR100","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nm.1959","volume":"15","author":"K Kessenbrock","year":"2009","unstructured":"Kessenbrock, K. et al. Netting neutrophils in autoimmune small-vessel vasculitis. Nat. Med. 15, 623\u2013625 (2009).","journal-title":"Nat. Med."},{"key":"709_CR101","first-page":"485","volume":"7","author":"E Corsiero","year":"2016","unstructured":"Corsiero, E., Pratesi, F., Prediletto, E., Bombardieri, M. & Migliorini, P. NETosis as source of autoantigens in rheumatoid arthritis. Front. Immunol. 7, 485 (2016).","journal-title":"Front. Immunol."},{"key":"709_CR102","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1365-2249.2002.02000.x","volume":"130","author":"E Grunebaum","year":"2002","unstructured":"Grunebaum, E. et al. The role of anti-endothelial cell antibodies in Kawasaki disease \u2013 in vitro and in vivo studies. Clin. Exp. Immunol. 130, 233\u2013240 (2002).","journal-title":"Clin. Exp. Immunol."},{"key":"709_CR103","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.cell.2020.09.016","volume":"183","author":"CR Consiglio","year":"2020","unstructured":"Consiglio, C. R. et al. The immunology of multisystem inflammatory syndrome in children with COVID-19. Cell 183, 968\u2013981.e7 (2020). On the basis of systems-level analyses of various immune cells, cytokines and autoantibodies, this article identifies shared and distinct immunological features of MIS-C and Kawasaki disease.","journal-title":"Cell"},{"key":"709_CR104","doi-asserted-by":"crossref","first-page":"251","DOI":"10.18176\/jiaci.0300","volume":"29","author":"Y Sakurai","year":"2019","unstructured":"Sakurai, Y. Autoimmune aspects of Kawasaki disease. J. Investig. Allergol. Clin. Immunol. 29, 251\u2013261 (2019).","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"709_CR105","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/rheumatology\/34.9.882","volume":"34","author":"MC Nash","year":"1995","unstructured":"Nash, M. C., Shah, V., Reader, J. A. & Dillon, M. J. Anti-neutrophil cytoplasmic antibodies and anti-endothelial cell antibodies are not increased in Kawasaki disease. Rheumatology 34, 882\u2013887 (1995).","journal-title":"Rheumatology"},{"key":"709_CR106","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/00006454-199008000-00003","volume":"9","author":"CR Li","year":"1990","unstructured":"Li, C. R., Yang, X. Q., Shen, J., Li, Y. B. & Jiang, L. P. Immunoglobulin G subclasses in serum and circulating immune complexes in patients with Kawasaki syndrome. Pediatr. Infect. Dis. J. 9, 544\u2013547 (1990).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"709_CR107","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1136\/bmj.290.6480.1456","volume":"290","author":"M Levin","year":"1985","unstructured":"Levin, M. et al. Platelet immune complex interaction in pathogenesis of Kawasaki disease and childhood polyarteritis. Br. Med. J. Clin. Res. Ed. 290, 1456\u20131460 (1985).","journal-title":"Br. Med. J. Clin. Res. Ed."},{"key":"709_CR108","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1253\/jcj.48.1350","volume":"48","author":"K Miyata","year":"1984","unstructured":"Miyata, K. et al. Circulation immune complexes and granulocytes chemotaxis in Kawasaki disease: the 8th conference on prevention for rheumatic fever and rheumatic heart disease. Jpn. Circ. J. 48, 1350\u20131353 (1984).","journal-title":"Jpn. Circ. J."},{"key":"709_CR109","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0022-3476(85)80073-1","volume":"106","author":"S Ono","year":"1985","unstructured":"Ono, S., Onimaru, T., Kawakami, K., Hokonohara, M. & Miyata, K. Impaired granulocyte chemotaxis and increased circulating immune complexes in Kawasaki disease. J. Pediatr. 106, 567\u2013570 (1985).","journal-title":"J. Pediatr."},{"key":"709_CR110","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/0091-6749(94)90362-X","volume":"93","author":"T Kohsaka","year":"1994","unstructured":"Kohsaka, T., Abe, J., Asahina, T. & Kobayashi, N. Classical pathway complement activation in Kawasaki syndrome. J. Allergy Clin. Immunol. 93, 520\u2013525 (1994).","journal-title":"J. Allergy Clin. Immunol."},{"key":"709_CR111","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/art.21529","volume":"54","author":"MH Biezeveld","year":"2006","unstructured":"Biezeveld, M. H. et al. Polymorphisms in the mannose-binding lectin gene as determinants of age-defined risk of coronary artery lesions in Kawasaki disease. Arthritis Rheum. 54, 369\u2013376 (2006).","journal-title":"Arthritis Rheum."},{"key":"709_CR112","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/j.1348-0421.1987.tb03150.x","volume":"31","author":"G Ohshio","year":"1987","unstructured":"Ohshio, G. et al. High levels of IgA-containing circulating immune complex and secretory IgA in Kawasaki disease. Microbiol. Immunol. 31, 891\u2013898 (1987).","journal-title":"Microbiol. Immunol."},{"key":"709_CR113","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41584-020-0426-0","volume":"16","author":"M Noval Rivas","year":"2020","unstructured":"Noval Rivas, M. & Arditi, M. Kawasaki disease: pathophysiology and insights from mouse models. Nat. Rev. Rheumatol. 16, 391\u2013405 (2020).","journal-title":"Nat. Rev. Rheumatol."},{"key":"709_CR114","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.immuni.2019.05.021","volume":"51","author":"M Noval Rivas","year":"2019","unstructured":"Noval Rivas, M. et al. Intestinal permeability and IgA provoke immune vasculitis linked to cardiovascular inflammation. Immunity 51, 508\u2013521.e6 (2019).","journal-title":"Immunity"},{"key":"709_CR115","first-page":"93","volume":"28","author":"B Olivito","year":"2010","unstructured":"Olivito, B. et al. Defective FOXP3 expression in patients with acute Kawasaki disease and restoration by intravenous immunoglobulin therapy. Clin. Exp. Rheumatol. 28, 93\u201397 (2010).","journal-title":"Clin. Exp. Rheumatol."},{"key":"709_CR116","doi-asserted-by":"crossref","first-page":"5837","DOI":"10.4049\/jimmunol.174.9.5837","volume":"174","author":"J Abe","year":"2005","unstructured":"Abe, J. et al. Gene expression profiling of the effect of high-dose intravenous Ig in patients with Kawasaki disease. J. Immunol. 174, 5837\u20135845 (2005).","journal-title":"J. Immunol."},{"key":"709_CR117","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00431-008-0872-1","volume":"168","author":"K Yoshimura","year":"2009","unstructured":"Yoshimura, K. et al. Increased nitric oxide production by neutrophils in early stage of Kawasaki disease. Eur. J. Pediatr. 168, 1037\u20131041 (2009).","journal-title":"Eur. J. Pediatr."},{"key":"709_CR118","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/art.37815","volume":"65","author":"Y Wang","year":"2013","unstructured":"Wang, Y. et al. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1\/Th2 cytokine profiles in patients with Kawasaki disease. Arthritis Rheum. 65, 805\u2013814 (2013).","journal-title":"Arthritis Rheum."},{"key":"709_CR119","doi-asserted-by":"publisher","DOI":"10.1172\/JCI147076","author":"YP Zhu","year":"2021","unstructured":"Zhu, Y. P. et al. Immune response to intravenous immunoglobulin in patients with Kawasaki disease and MIS-C. J. Clin. Invest. https:\/\/doi.org\/10.1172\/JCI147076 (2021).","journal-title":"J. Clin. Invest."},{"key":"709_CR120","volume":"12","author":"Z Wang","year":"2021","unstructured":"Wang, Z. et al. Single-cell RNA sequencing of peripheral blood mononuclear cells from acute Kawasaki disease patients. Nat. Commun. 12, 5444 (2021). This article applies single-cell RNA sequencing to report that monocytes are the major contributors of inflammatory responses, including IL-1\u03b2 and TNF, in Kawasaki disease.","journal-title":"Nat. Commun."},{"key":"709_CR121","doi-asserted-by":"crossref","first-page":"102850","DOI":"10.1016\/j.autrev.2021.102850","volume":"20","author":"N Rambabu","year":"2021","unstructured":"Rambabu, N., Mathew, M. J., Kaveri, S. V. & Bayry, J. Boolean analysis of the transcriptomic data to identify novel biomarkers of IVIG response. Autoimmun. Rev. 20, 102850 (2021).","journal-title":"Autoimmun. Rev."},{"key":"709_CR122","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1161\/CIRCULATIONAHA.120.048360","volume":"142","author":"Z Belhadjer","year":"2020","unstructured":"Belhadjer, Z. et al. Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic. Circulation 142, 429\u2013436 (2020).","journal-title":"Circulation"},{"key":"709_CR123","unstructured":"CDC. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Coronavirus Disease 2019 (COVID-19). Health Alert Network https:\/\/emergency.cdc.gov\/han\/2020\/han00432.asp (2020)."},{"key":"709_CR124","unstructured":"CDC. COVID Data Tracker. https:\/\/covid.cdc.gov\/covid-data-tracker (2020)."},{"key":"709_CR125","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jpeds.2020.06.045","volume":"224","author":"S Kaushik","year":"2020","unstructured":"Kaushik, S. et al. Multisystem inflammatory syndrome in children associated with severe acute respiratory syndrome coronavirus 2 infection (MIS-C): a multi-institutional study from New York City. J. Pediatr. 224, 24\u201329 (2020).","journal-title":"J. Pediatr."},{"key":"709_CR126","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S2352-4642(20)30215-7","volume":"4","author":"P Davies","year":"2020","unstructured":"Davies, P. et al. Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study. Lancet Child Adolesc. Health 4, 669\u2013677 (2020).","journal-title":"Lancet Child Adolesc. Health"},{"key":"709_CR127","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/annrheumdis-2020-217960","volume":"79","author":"M Pouletty","year":"2020","unstructured":"Pouletty, M. et al. Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort. Ann. Rheum. Dis. 79, 999\u20131006 (2020). An early report of MIS-C from the first wave of COVID-19 in mid-2020.","journal-title":"Ann. Rheum. Dis."},{"key":"709_CR128","doi-asserted-by":"crossref","first-page":"m2094","DOI":"10.1136\/bmj.m2094","volume":"369","author":"J Toubiana","year":"2020","unstructured":"Toubiana, J. et al. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. BMJ 369, m2094 (2020). An early report of MIS-C from the first wave of COVID-19 in mid-2020.","journal-title":"BMJ"},{"key":"709_CR129","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jpeds.2020.06.044","volume":"224","author":"CA Capone","year":"2020","unstructured":"Capone, C. A. et al. Characteristics, cardiac involvement, and outcomes of multisystem inflammatory syndrome of childhood associated with severe acute respiratory syndrome coronavirus 2 Infection. J. Pediatr. 224, 141\u2013145 (2020).","journal-title":"J. Pediatr."},{"key":"709_CR130","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1148\/radiol.2020202543","volume":"298","author":"S Hameed","year":"2020","unstructured":"Hameed, S. et al. Spectrum of imaging findings on chest radiographs, US, CT, and MRI images in multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19. Radiology 298, E1\u2013E10 (2020).","journal-title":"Radiology"},{"key":"709_CR131","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1001\/jama.2020.10369","volume":"324","author":"E Whittaker","year":"2020","unstructured":"Whittaker, E. et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA 324, 259\u2013269 (2020).","journal-title":"JAMA"},{"key":"709_CR132","doi-asserted-by":"crossref","first-page":"e397","DOI":"10.1093\/cid\/ciaa1042","volume":"72","author":"C Moraleda","year":"2020","unstructured":"Moraleda, C. et al. Multi-inflammatory syndrome in children related to SARS-CoV-2 in Spain. Clin. Infect. Dis. 72, e397\u2013e401 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"709_CR133","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1007\/s13312-020-2025-1","volume":"57","author":"K Dhanalakshmi","year":"2020","unstructured":"Dhanalakshmi, K. et al. Epidemiological and clinical profile of pediatric inflammatory multisystem syndrome \u2014 temporally associated with SARS-CoV-2 (PIMS-TS) in Indian children. Indian. Pediatr. 57, 1010\u20131014 (2020).","journal-title":"Indian. Pediatr."},{"key":"709_CR134","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1053\/j.gastro.2020.05.079","volume":"159","author":"J Miller","year":"2020","unstructured":"Miller, J. et al. Gastrointestinal symptoms as a major presentation component of a novel multisystem inflammatory syndrome in children that is related to coronavirus disease 2019: a single center experience of 44 cases. Gastroenterology 159, 1571\u20131574.e2 (2020).","journal-title":"Gastroenterology"},{"key":"709_CR135","doi-asserted-by":"crossref","first-page":"2001010","DOI":"10.2807\/1560-7917.ES.2020.25.22.2001010","volume":"25","author":"A Belot","year":"2020","unstructured":"Belot, A. et al. SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020. Eurosurveillance 25, 2001010 (2020).","journal-title":"Eurosurveillance"},{"key":"709_CR136","doi-asserted-by":"crossref","first-page":"5942","DOI":"10.1172\/JCI141113","volume":"130","author":"PY Lee","year":"2020","unstructured":"Lee, P. Y. et al. Distinct clinical and immunological features of SARS\u2013CoV-2\u2013induced multisystem inflammatory syndrome in children. J. Clin. Invest. 130, 5942\u20135950 (2020).","journal-title":"J. Clin. Invest."},{"key":"709_CR137","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jmv.26224","volume":"93","author":"M Riollano-Cruz","year":"2021","unstructured":"Riollano-Cruz, M. et al. Multisystem inflammatory syndrome in children related to COVID-19: a New York City experience. J. Med. Virol. 93, 424\u2013433 (2021).","journal-title":"J. Med. Virol."},{"key":"709_CR138","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s00246-020-02391-2","volume":"41","author":"T Ramcharan","year":"2020","unstructured":"Ramcharan, T. et al. Paediatric inflammatory multisystem syndrome: temporally associated with SARS-CoV-2 (PIMS-TS): cardiac features, management and short-term outcomes at a UK tertiary paediatric hospital. Pediatr. Cardiol. 41, 1391\u20131401 (2020).","journal-title":"Pediatr. Cardiol."},{"key":"709_CR139","doi-asserted-by":"crossref","DOI":"10.1186\/s13613-020-00690-8","volume":"10","author":"M Grimaud","year":"2020","unstructured":"Grimaud, M. et al. Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill children. Ann. Intensive Care 10, 69 (2020).","journal-title":"Ann. Intensive Care"},{"key":"709_CR140","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1111\/pai.13504","volume":"32","author":"M Perez-Toledo","year":"2021","unstructured":"Perez-Toledo, M. et al. SARS-CoV-2-specific IgG1\/IgG3 but not IgM in children with pediatric inflammatory multi-system syndrome. Pediatr. Allergy Immunol. 32, 1125\u20131129 (2021).","journal-title":"Pediatr. Allergy Immunol."},{"key":"709_CR141","unstructured":"RCPCH. Paediatric multisystem inflammatory syndrome temporally associated with COVID-19. https:\/\/www.rcpch.ac.uk\/resources\/guidance-paediatric-multisystem-inflammatory-syndrome-temporally-associated-covid-19 (2020)."},{"key":"709_CR142","unstructured":"WHO. Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19. https:\/\/www.who.int\/news-room\/commentaries\/detail\/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19 (2020)."},{"key":"709_CR143","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jpeds.2020.10.013","volume":"229","author":"RF Carlin","year":"2021","unstructured":"Carlin, R. F. et al. Discriminating multisystem inflammatory syndrome in children requiring treatment from common febrile conditions in outpatient settings. J. Pediatr. 229, 26\u201332.e2 (2021).","journal-title":"J. Pediatr."},{"key":"709_CR144","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2021-322290","author":"JE Roberts","year":"2021","unstructured":"Roberts, J. E. et al. Differentiating multisystem inflammatory syndrome in children: a single-centre retrospective cohort study. Arch. Dis. Child. https:\/\/doi.org\/10.1136\/archdischild-2021-322290 (2021).","journal-title":"Arch. Dis. Child."},{"key":"709_CR145","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-020-03332-4","volume":"24","author":"A Garc\u00eda-Salido","year":"2020","unstructured":"Garc\u00eda-Salido, A. et al. Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain. Crit. Care 24, 666 (2020).","journal-title":"Crit. Care"},{"key":"709_CR146","doi-asserted-by":"crossref","first-page":"100433","DOI":"10.1016\/j.eclinm.2020.100433","volume":"24","author":"A Hoang","year":"2020","unstructured":"Hoang, A. et al. COVID-19 in 7780 pediatric patients: a systematic review. EClinicalMedicine 24, 100433 (2020).","journal-title":"EClinicalMedicine"},{"key":"709_CR147","doi-asserted-by":"crossref","first-page":"m1990","DOI":"10.1136\/bmj.m1990","volume":"369","author":"E Mahase","year":"2020","unstructured":"Mahase, E. Covid-19: cases of inflammatory syndrome in children surge after urgent alert. BMJ 369, m1990 (2020).","journal-title":"BMJ"},{"key":"709_CR148","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1002\/art.41454","volume":"72","author":"LA Henderson","year":"2020","unstructured":"Henderson, L. A. et al. American College of Rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS\u2013CoV-2 and Hyperinflammation in pediatric COVID-19: Version 1. Arthritis Rheumatol. 72, 1791\u20131805 (2020). Guidelines article on the management of MIS-C.","journal-title":"Arthritis Rheumatol."},{"key":"709_CR149","first-page":"e13","volume":"73","author":"LA Henderson","year":"2021","unstructured":"Henderson, L. A. et al. American College of Rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: Version 2. Arthritis Rheumatol. 73, e13\u2013e29 (2021). Guidelines article on the management of MIS-C.","journal-title":"Arthritis Rheumatol."},{"key":"709_CR150","doi-asserted-by":"crossref","first-page":"5967","DOI":"10.1172\/JCI140970","volume":"130","author":"C Diorio","year":"2020","unstructured":"Diorio, C. et al. Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS\u2013CoV-2. J. Clin. Invest. 130, 5967\u20135975 (2020).","journal-title":"J. Clin. Invest."},{"key":"709_CR151","doi-asserted-by":"crossref","first-page":"100850","DOI":"10.1016\/j.eclinm.2021.100850","volume":"35","author":"AN Duarte-Neto","year":"2021","unstructured":"Duarte-Neto, A. N. et al. An autopsy study of the spectrum of severe COVID-19 in children: from SARS to different phenotypes of MIS-C. EclinicalMed 35, 100850 (2021).","journal-title":"EclinicalMed"},{"key":"709_CR152","doi-asserted-by":"crossref","first-page":"149633","DOI":"10.1172\/JCI149633","volume":"131","author":"LM Yonker","year":"2021","unstructured":"Yonker, L. M. et al. Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier. J. Clin. Invest. 131, 149633 (2021). A report on the implication of zonulin-dependent loss of intestinal mucosal permeability in the pathogenesis of MIS-C and the therapeutic application of zonulin antagonist larazotide.","journal-title":"J. Clin. Invest."},{"key":"709_CR153","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.immuni.2021.04.003","volume":"54","author":"A Ramaswamy","year":"2021","unstructured":"Ramaswamy, A. et al. Immune dysregulation and autoreactivity correlate with disease severity in SARS-CoV-2-associated multisystem inflammatory syndrome in children. Immunity 54, 1083\u20131095.e7 (2021). Use of single-cell RNA sequencing, flow cytometry, unbiased serum proteomics and TCR repertoire analysis to identify the signatures of severity in MIS-C.","journal-title":"Immunity"},{"key":"709_CR154","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.cell.2020.09.034","volume":"183","author":"CN Gruber","year":"2020","unstructured":"Gruber, C. N. et al. Mapping systemic inflammation and antibody responses in multisystem inflammatory syndrome in children (MIS-C). Cell 183, 982\u2013995.e14 (2020). Mapping of systemic inflammation and autoantibodies in MIS-C.","journal-title":"Cell"},{"key":"709_CR155","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2020-018242","volume":"146","author":"CA Rostad","year":"2020","unstructured":"Rostad, C. A. et al. Quantitative SARS-CoV-2 serology in children with multisystem inflammatory syndrome (MIS-C). Pediatrics 146, e2020018242 (2020).","journal-title":"Pediatrics"},{"key":"709_CR156","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41590-020-00826-9","volume":"22","author":"SP Weisberg","year":"2021","unstructured":"Weisberg, S. P. et al. Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum. Nat. Immunol. 22, 25\u201331 (2021).","journal-title":"Nat. Immunol."},{"key":"709_CR157","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/jpids\/piaa161","volume":"10","author":"EM Anderson","year":"2020","unstructured":"Anderson, E. M. et al. SARS-CoV-2 antibody responses in children with MIS-C and mild and severe COVID-19. J. Pediatr. Infect. Dis. Soc. 10, 669\u2013673 (2020).","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"709_CR158","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41591-021-01263-3","volume":"27","author":"YC Bartsch","year":"2021","unstructured":"Bartsch, Y. C. et al. Humoral signatures of protective and pathological SARS-CoV-2 infection in children. Nat. Med. 27, 454\u2013462 (2021). This article reports that children with MIS-C maintain Fc\u03b3R-binding, inflammatory monocyte\/macrophage-activating SARS-CoV-2 IgG antibodies.","journal-title":"Nat. Med."},{"key":"709_CR159","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1126\/science.abd3871","volume":"370","author":"J Mateus","year":"2020","unstructured":"Mateus, J. et al. Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans. Science 370, 89\u201394 (2020).","journal-title":"Science"},{"key":"709_CR160","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","volume":"181","author":"A Grifoni","year":"2020","unstructured":"Grifoni, A. et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell 181, 1489\u20131501.e15 (2020).","journal-title":"Cell"},{"key":"709_CR161","doi-asserted-by":"crossref","first-page":"2001782","DOI":"10.2807\/1560-7917.ES.2021.26.13.2001782","volume":"26","author":"I Sermet-Gaudelus","year":"2021","unstructured":"Sermet-Gaudelus, I. et al. Prior infection by seasonal coronaviruses, as assessed by serology, does not prevent SARS-CoV-2 infection and disease in children, France, April to June 2020. Eur. Surveill. 26, 2001782 (2021).","journal-title":"Eur. Surveill."},{"key":"709_CR162","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jaci.2020.10.008","volume":"147","author":"MN Rivas","year":"2021","unstructured":"Rivas, M. N., Porritt, R. A., Cheng, M. H., Bahar, I. & Arditi, M. COVID-19\u2013associated multisystem inflammatory syndrome in children (MIS-C): a novel disease that mimics toxic shock syndrome \u2014 the superantigen hypothesis. J. Allergy Clin. Immunol. 147, 57\u201359 (2021).","journal-title":"J. Allergy Clin. Immunol."},{"key":"709_CR163","doi-asserted-by":"crossref","first-page":"25254","DOI":"10.1073\/pnas.2010722117","volume":"117","author":"MH Cheng","year":"2020","unstructured":"Cheng, M. H. et al. Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation. Proc. Natl Acad. Sci. USA 117, 25254\u201325262 (2020). Evidence that SARS-CoV-2 spike protein acts as a superantigen leading to HLA class I-associated expansion of TRBV11-2 T cells in MIS-C.","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"709_CR164","volume":"131","author":"RA Porritt","year":"2021","unstructured":"Porritt, R. A. et al. HLA class I-associated expansion of TRBV11-2 T cells in multisystem inflammatory syndrome in children. J. Clin. Invest. 131, e146614 (2021). Evidence that SARS-CoV-2 spike protein acts as a superantigen leading to HLA class I-associated expansion of TRBV11-2 T cells in MIS-C.","journal-title":"J. Clin. Invest."},{"key":"709_CR165","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abh1516","volume":"6","author":"M Moreews","year":"2021","unstructured":"Moreews, M. et al. Polyclonal expansion of TCR V\u03b2 21.3+ CD4+ and CD8+ T cells is a hallmark of multisystem inflammatory syndrome in children. Sci. Immunol. 6, eabh1516 (2021). Patients with MIS-C present a unique CD4+ and CD8+ T cell TCR repertoire with a polyclonal expansion of CX3CR1-expressing activated (TRBV11-2)\/V\u03b221.3+ clonotype.","journal-title":"Sci. Immunol."},{"key":"709_CR166","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1146\/annurev.micro.55.1.77","volume":"55","author":"JK McCormick","year":"2001","unstructured":"McCormick, J. K., Yarwood, J. M. & Schlievert, P. M. Toxic shock syndrome and bacterial superantigens: an update. Annu. Rev. Microbiol. 55, 77\u2013104 (2001).","journal-title":"Annu. Rev. Microbiol."},{"key":"709_CR167","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.3390\/nu12092757","volume":"12","author":"A Radujkovic","year":"2020","unstructured":"Radujkovic, A. et al. Vitamin D deficiency and outcome of COVID-19 patients. Nutrients 12, 2757 (2020).","journal-title":"Nutrients"},{"key":"709_CR168","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.3945\/ajcn.2009.29094","volume":"91","author":"M Urashima","year":"2010","unstructured":"Urashima, M. et al. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am. J. Clin. Nutr. 91, 1255\u20131260 (2010).","journal-title":"Am. J. Clin. Nutr."},{"key":"709_CR169","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3389\/fimmu.2015.00639","volume":"6","author":"S Omenetti","year":"2015","unstructured":"Omenetti, S. & Pizarro, T. T. The Treg\/TH17 axis: a dynamic balance regulated by the gut microbiome. Front. Immunol. 6, 639 (2015).","journal-title":"Front. Immunol."},{"key":"709_CR170","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1136\/gutjnl-2020-323020","volume":"70","author":"YK Yeoh","year":"2021","unstructured":"Yeoh, Y. K. et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut 70, 698\u2013706 (2021).","journal-title":"Gut"},{"key":"709_CR171","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1053\/j.gastro.2020.06.048","volume":"159","author":"T Zuo","year":"2020","unstructured":"Zuo, T. et al. Alterations in fecal fungal microbiome of patients with COVID-19 during time of hospitalization until discharge. Gastroenterology 159, 1302\u20131310.e5 (2020).","journal-title":"Gastroenterology"},{"key":"709_CR172","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01777-21","volume":"12","author":"C Merenstein","year":"2021","unstructured":"Merenstein, C. et al. Signatures of COVID-19 severity and immune response in the respiratory tract microbiome. mBio 12, e0177721 (2021).","journal-title":"mBio"},{"key":"709_CR173","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1053\/j.gastro.2020.05.048","volume":"159","author":"T Zuo","year":"2020","unstructured":"Zuo, T. et al. Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology 159, 944\u2013955.e8 (2020).","journal-title":"Gastroenterology"},{"key":"709_CR174","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgg.2021.05.004","author":"R Xu","year":"2021","unstructured":"Xu, R. et al. Progressive deterioration of the upper respiratory tract and the gut microbiomes in children during the early infection stages of COVID-19. J. Genet. Genomics https:\/\/doi.org\/10.1016\/j.jgg.2021.05.004 (2021).","journal-title":"J. Genet. Genomics"},{"key":"709_CR175","doi-asserted-by":"crossref","unstructured":"Hurst, J. H. et al. Age-related changes in the upper respiratory microbiome are associated with SARS-CoV-2 susceptibility and illness severity. Preprint at medRxiv https:\/\/www.medrxiv.org\/content\/10.1101\/2021.03.20.21252680v1 (2021).","DOI":"10.1101\/2021.03.20.21252680"},{"key":"709_CR176","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.jaci.2021.06.024","volume":"148","author":"J Chou","year":"2021","unstructured":"Chou, J. et al. Mechanisms underlying genetic susceptibility to multisystem inflammatory syndrome in children (MIS-C). J. Allergy Clin. Immunol. 148, 732\u2013738.e1 (2021).","journal-title":"J. Allergy Clin. Immunol."},{"key":"709_CR177","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/jamapediatrics.2021.0630","volume":"175","author":"ED Belay","year":"2021","unstructured":"Belay, E. D. et al. Trends in geographic and temporal distribution of US children with multisystem inflammatory syndrome during the COVID-19 pandemic. JAMA Pediatr. 175, 837\u2013845 (2021).","journal-title":"JAMA Pediatr."},{"key":"709_CR178","doi-asserted-by":"crossref","first-page":"474","DOI":"10.7326\/M20-2223","volume":"173","author":"L Krishnan","year":"2020","unstructured":"Krishnan, L., Ogunwole, S. M. & Cooper, L. A. Historical insights on coronavirus disease 2019 (COVID-19), the 1918 influenza pandemic, and racial disparities: illuminating a path forward. Ann. Intern. Med. 173, 474\u2013481 (2020).","journal-title":"Ann. Intern. Med."},{"key":"709_CR179","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.3390\/jcm9082442","volume":"9","author":"DJ Alcendor","year":"2020","unstructured":"Alcendor, D. J. Racial disparities-associated COVID-19 mortality among minority populations in the US. J. Clin. Med. 9, 2442 (2020).","journal-title":"J. Clin. Med."},{"key":"709_CR180","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jiph.2021.01.008","volume":"14","author":"MS Rafferty","year":"2021","unstructured":"Rafferty, M. S. et al. Multisystem inflammatory syndrome in children (MIS-C) and the coronavirus pandemic: current knowledge and implications for public health. J. Infect. Public Health 14, 484\u2013494 (2021).","journal-title":"J. Infect. Public Health"},{"key":"709_CR181","first-page":"e00510","volume":"94","author":"A Nguyen","year":"2020","unstructured":"Nguyen, A. et al. Human leukocyte antigen susceptibility map for severe acute respiratory syndrome coronavirus 2. J. Virol. 94, e00510\u2013e00520 (2020).","journal-title":"J. Virol."},{"key":"709_CR182","volume":"370","author":"Q Zhang","year":"2020","unstructured":"Zhang, Q. et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science 370, eabd4570v (2020).","journal-title":"Science"},{"key":"709_CR183","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5802\/crbiol.36","volume":"344","author":"P Bastard","year":"2021","unstructured":"Bastard, P. et al. Insufficient type I IFN immunity underlies life-threatening COVID-19 pneumonia. C. R. Biol. 344, 19\u201325 (2021).","journal-title":"C. R. Biol."},{"key":"709_CR184","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.jaci.2020.07.033","volume":"146","author":"PY Lee","year":"2020","unstructured":"Lee, P. Y. et al. Immune dysregulation and multisystem inflammatory syndrome in children (MIS-C) in individuals with haploinsufficiency of SOCS1. J. Allergy Clin. Immunol. 146, 1194\u20131200.e1 (2020). This article provides the first evidence on genetic susceptibility to MIS-C.","journal-title":"J. Allergy Clin. Immunol."},{"key":"709_CR185","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abf7570","volume":"6","author":"LA Vella","year":"2021","unstructured":"Vella, L. A. et al. Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19. Sci. Immunol. 6, eabf7570 (2021). The article identifies a unique and strong activation of vascular patrolling CX3CR1+ CD8+ T cells in MIS-C.","journal-title":"Sci. Immunol."},{"key":"709_CR186","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1038\/s41591-020-1054-6","volume":"26","author":"MJ Carter","year":"2020","unstructured":"Carter, M. J. et al. Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection. Nat. Med. 26, 1701\u20131707 (2020). Based on the immunoprofiling of MIS-C patients, this article suggests that MIS-C might represent a distinct immunopathogenic disease.","journal-title":"Nat. Med."},{"key":"709_CR187","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd5487","volume":"12","author":"CA Pierce","year":"2020","unstructured":"Pierce, C. A. et al. Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients. Sci. Transl. Med. 12, eabd5487 (2020).","journal-title":"Sci. Transl. Med."},{"key":"709_CR188","doi-asserted-by":"crossref","first-page":"654587","DOI":"10.3389\/fimmu.2021.654587","volume":"12","author":"F Caldarale","year":"2021","unstructured":"Caldarale, F. et al. Plasmacytoid dendritic cells depletion and elevation of IFN-\u03b3 dependent chemokines CXCL9 and CXCL10 in children with multisystem inflammatory syndrome. Front. Immunol. 12, 654587 (2021).","journal-title":"Front. Immunol."},{"key":"709_CR189","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/infdis\/jiab285","volume":"224","author":"N Peart Akindele","year":"2021","unstructured":"Peart Akindele, N. et al. Distinct cytokine and chemokine dysregulation in hospitalized children with acute COVID-19 and multisystem inflammatory syndrome with similar levels of nasopharyngeal SARS-CoV-2 shedding. J. Infect. Dis. 224, 606\u2013615 (2021).","journal-title":"J. Infect. Dis."},{"key":"709_CR190","doi-asserted-by":"crossref","unstructured":"Diorio, C. et al. Proteomic profiling of MIS-C patients reveals heterogeneity relating to interferon gamma dysregulation and vascular endothelial dysfunction. Preprint at medRxiv https:\/\/www.medrxiv.org\/content\/10.1101\/2021.04.13.21255439v1 (2021).","DOI":"10.1101\/2021.04.13.21255439"},{"key":"709_CR191","volume":"5","author":"Y Zuo","year":"2020","unstructured":"Zuo, Y. et al. Neutrophil extracellular traps in COVID-19. JCI Insight 5, e138999 (2020).","journal-title":"JCI Insight"},{"key":"709_CR192","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1182\/blood.2020007008","volume":"136","author":"EA Middleton","year":"2020","unstructured":"Middleton, E. A. et al. Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood 136, 1169\u20131179 (2020).","journal-title":"Blood"},{"key":"709_CR193","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218593","author":"K Yamashita","year":"2020","unstructured":"Yamashita, K., Takaori-Kondo, A. & Mizugishi, K. Exaggerated neutrophil extracellular trap formation in Kawasaki disease: a key phenomenon behind the outbreak in western countries? Ann. Rheum. Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218593 (2020).","journal-title":"Ann. Rheum. Dis."},{"key":"709_CR194","doi-asserted-by":"crossref","first-page":"103357","DOI":"10.1016\/j.ebiom.2021.103357","volume":"67","author":"V Seery","year":"2021","unstructured":"Seery, V. et al. Blood neutrophils from children with COVID-19 exhibit both inflammatory and anti-inflammatory markers. EBioMedicine 67, 103357 (2021).","journal-title":"EBioMedicine"},{"key":"709_CR195","volume":"12","author":"ND Beckmann","year":"2021","unstructured":"Beckmann, N. D. et al. Downregulation of exhausted cytotoxic T cells in gene expression networks of multisystem inflammatory syndrome in children. Nat. Commun. 12, 4854 (2021).","journal-title":"Nat. Commun."},{"key":"709_CR196","doi-asserted-by":"crossref","first-page":"617089","DOI":"10.3389\/fimmu.2020.617089","volume":"11","author":"A Vojdani","year":"2020","unstructured":"Vojdani, A., Vojdani, E. & Kharrazian, D. Reaction of human monoclonal antibodies to SARS-CoV-2 proteins with tissue antigens: implications for autoimmune diseases. Front. Immunol. 11, 617089 (2020).","journal-title":"Front. Immunol."},{"key":"709_CR197","doi-asserted-by":"crossref","unstructured":"An, H. & Park, J. Molecular mimicry map (3M) of SARS-CoV-2: prediction of potentially immunopathogenic SARS-CoV-2 epitopes via a novel immunoinformatic approach. Preprint at bioRxiv https:\/\/www.biorxiv.org\/content\/10.1101\/2020.11.12.344424v1 (2020).","DOI":"10.1101\/2020.11.12.344424"},{"key":"709_CR198","unstructured":"European Centre for Disease Prevention and Control. Rapid risk assessment: paediatric inflammatory multisystem syndrome and SARS-CoV-2 infection in children. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/paediatric-inflammatory-multisystem-syndrome-and-sars-cov-2-rapid-risk-assessment (2020)."},{"key":"709_CR199","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.1182\/bloodadvances.2020003471","volume":"4","author":"C Diorio","year":"2020","unstructured":"Diorio, C. et al. Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations. Blood Adv. 4, 6051\u20136063 (2020).","journal-title":"Blood Adv."},{"key":"709_CR200","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1182\/blood.2020010218","volume":"138","author":"HB Whitworth","year":"2021","unstructured":"Whitworth, H. B. et al. Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C. Blood 138, 190\u2013198 (2021).","journal-title":"Blood"},{"key":"709_CR201","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.imbio.2006.01.003","volume":"211","author":"Y Endo","year":"2006","unstructured":"Endo, Y., Takahashi, M. & Fujita, T. Lectin complement system and pattern recognition. Immunobiology 211, 283\u2013293 (2006).","journal-title":"Immunobiology"},{"key":"709_CR202","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1126\/science.abb9983","volume":"369","author":"Y Watanabe","year":"2020","unstructured":"Watanabe, Y., Allen, J. D., Wrapp, D., McLellan, J. S. & Crispin, M. Site-specific glycan analysis of the SARS-CoV-2 spike. Science 369, 330\u2013333 (2020).","journal-title":"Science"},{"key":"709_CR203","doi-asserted-by":"crossref","first-page":"604512","DOI":"10.3389\/fimmu.2020.604512","volume":"11","author":"A Polycarpou","year":"2020","unstructured":"Polycarpou, A., Grigoriadou, S., Klavinskis, L. & Sacks, S. Does the lectin complement pathway link Kawasaki disease and SARS-CoV-2? Front. Immunol. 11, 604512 (2020).","journal-title":"Front. Immunol."},{"key":"709_CR204","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jpeds.2020.10.026","volume":"229","author":"ML Dove","year":"2021","unstructured":"Dove, M. L. et al. Multisystem inflammatory syndrome in children: survey of protocols for early hospital evaluation and management. J. Pediatr. 229, 33\u201340 (2021).","journal-title":"J. Pediatr."},{"key":"709_CR205","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1097\/PCC.0000000000002598","volume":"22","author":"B Jonat","year":"2021","unstructured":"Jonat, B. et al. Multisystem inflammatory syndrome in children associated with coronavirus disease 2019 in a children\u2019s hospital in New York City: patient characteristics and an institutional protocol for evaluation, management, and follow-up. Pediatr. Crit. Care Med. 22, e178\u2013e191 (2021).","journal-title":"Pediatr. Crit. Care Med."},{"key":"709_CR206","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1001\/jama.2021.0694","volume":"325","author":"N Ouldali","year":"2021","unstructured":"Ouldali, N. et al. Association of intravenous immunoglobulins plus methylprednisolone vs immunoglobulins alone with course of fever in multisystem inflammatory syndrome in children. JAMA 325, 855\u2013864 (2021).","journal-title":"JAMA"},{"key":"709_CR207","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa2102968","volume":"385","author":"AJ McArdle","year":"2021","unstructured":"McArdle, A. J. et al. Treatment of multisystem inflammatory syndrome in children. N. Engl. J. Med. 385, 11\u201322 (2021). This is an international observational cohort study aimed at supporting the treatment decisions in patients with MIS-C.","journal-title":"N. Engl. J. Med."},{"key":"709_CR208","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1017\/S1047951117002864","volume":"28","author":"M-P Guillaume","year":"2018","unstructured":"Guillaume, M.-P., Reumaux, H. & Dubos, F. Usefulness and safety of anakinra in refractory Kawasaki disease complicated by coronary artery aneurysm. Cardiol. Young. 28, 739\u2013742 (2018).","journal-title":"Cardiol. Young."},{"key":"709_CR209","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.autrev.2018.01.024","volume":"17","author":"I Kone-Paut","year":"2018","unstructured":"Kone-Paut, I. et al. The use of interleukin 1 receptor antagonist (anakinra) in Kawasaki disease: a retrospective cases series. Autoimmun. Rev. 17, 768\u2013774 (2018).","journal-title":"Autoimmun. Rev."},{"key":"709_CR210","doi-asserted-by":"crossref","first-page":"e276","DOI":"10.1016\/S1473-3099(20)30651-4","volume":"20","author":"L Jiang","year":"2020","unstructured":"Jiang, L. et al. COVID-19 and multisystem inflammatory syndrome in children and adolescents. Lancet Infect. Dis. 20, e276\u2013e288 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"709_CR211","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1001\/jama.2021.2091","volume":"325","author":"LR Feldstein","year":"2021","unstructured":"Feldstein, L. R. et al. Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19. JAMA 325, 1074\u20131087 (2021).","journal-title":"JAMA"},{"key":"709_CR212","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1007\/s00431-021-03993-5","volume":"180","author":"L Hoste","year":"2021","unstructured":"Hoste, L., Van Paemel, R. & Haerynck, F. Multisystem inflammatory syndrome in children related to COVID-19: a systematic review. Eur. J. Pediatr. 180, 2019\u20132034 (2021).","journal-title":"Eur. J. Pediatr."},{"key":"709_CR213","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s00246-014-0915-5","volume":"35","author":"Q-Q Xu","year":"2014","unstructured":"Xu, Q.-Q. et al. Evaluation of left ventricular systolic strain in children with Kawasaki disease. Pediatr. Cardiol. 35, 1191\u20131197 (2014).","journal-title":"Pediatr. Cardiol."},{"key":"709_CR214","doi-asserted-by":"crossref","unstructured":"Surve, S. V., Joseph, S., Gajbhiye, R. K., Mahale, S. D. & Modi, D. N. A systematic review on multisystem inflammatory syndrome in children (MIS-C) with COVID-19: development of a scoring system for clinical diagnosis. Preprint at medRxiv https:\/\/www.medrxiv.org\/content\/10.1101\/2021.04.23.21255879v1 (2021).","DOI":"10.1101\/2021.04.23.21255879"},{"key":"709_CR215","unstructured":"Sahoo, D. et al. An AI-guided invariant signature places MIS-C with Kawasaki disease in a continuum of host immune responses. Preprint at bioRxiv https:\/\/www.biorxiv.org\/content\/10.1101\/2021.04.11.439347v2 (2021)."},{"key":"709_CR216","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1056\/NEJM199106063242305","volume":"324","author":"JW Newburger","year":"1991","unstructured":"Newburger, J. W. et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N. Engl. J. Med. 324, 1633\u20131639 (1991).","journal-title":"N. Engl. J. Med."},{"key":"709_CR217","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jpeds.2020.08.003","volume":"226","author":"JY Abrams","year":"2020","unstructured":"Abrams, J. Y. et al. Multisystem inflammatory syndrome in children associated with severe acute respiratory syndrome coronavirus 2: a systematic review. J. Pediatr. 226, 45\u201354.e1 (2020).","journal-title":"J. Pediatr."},{"key":"709_CR218","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S2352-4642(20)30175-9","volume":"4","author":"N Ouldali","year":"2020","unstructured":"Ouldali, N. et al. Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis. Lancet Child. Adolesc. Health 4, 662\u2013668 (2020).","journal-title":"Lancet Child. Adolesc. Health"},{"key":"709_CR219","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.3201\/eid2704.210026","volume":"27","author":"YJ Choe","year":"2021","unstructured":"Choe, Y. J. et al. Surveillance of COVID-19-associated multisystem inflammatory syndrome in children, South Korea. Emerg. Infect. Dis. 27, 1196\u20131200 (2021).","journal-title":"Emerg. Infect. Dis."},{"key":"709_CR220","doi-asserted-by":"crossref","first-page":"873","DOI":"10.21037\/tp-20-151","volume":"9","author":"W Li","year":"2020","unstructured":"Li, W., Tang, Y., Shi, Y., Chen, Y. & Liu, E. Why multisystem inflammatory syndrome in children has been less commonly described in Asia? Transl. Pediatr. 9, 873\u2013875 (2020).","journal-title":"Transl. Pediatr."},{"key":"709_CR221","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.2008-0730","volume":"124","author":"MBF Son","year":"2009","unstructured":"Son, M. B. F. et al. Treatment of Kawasaki disease: analysis of 27 US pediatric hospitals from 2001 to 2006. Pediatrics 124, 1\u20138 (2009).","journal-title":"Pediatrics"},{"key":"709_CR222","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/archdischild-2017-313694","volume":"103","author":"ER Coon","year":"2018","unstructured":"Coon, E. R., Wilkes, J., Bratton, S. L. & Srivastava, R. Paediatric overdiagnosis modelled by coronary abnormality trends in Kawasaki disease. Arch. Dis. Child. 103, 937\u2013941 (2018).","journal-title":"Arch. Dis. Child."},{"key":"709_CR223","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3390\/diagnostics3020232","volume":"3","author":"SJ Ghelani","year":"2013","unstructured":"Ghelani, S. J., Kwatra, N. S. & Spurney, C. F. Can coronary artery involvement in Kawasaki disease be predicted? Diagnostics 3, 232\u2013243 (2013).","journal-title":"Diagnostics"},{"key":"709_CR224","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jpeds.2006.01.039","volume":"148","author":"GWK Gong","year":"2006","unstructured":"Gong, G. W. K., McCrindle, B. W., Ching, J. C. & Yeung, R. S. M. Arthritis presenting during the acute phase of Kawasaki disease. J. Pediatr. 148, 800\u2013805 (2006).","journal-title":"J. Pediatr."},{"key":"709_CR225","doi-asserted-by":"crossref","first-page":"E283","DOI":"10.1148\/radiol.2020202288","volume":"297","author":"E Blondiaux","year":"2020","unstructured":"Blondiaux, E. et al. Cardiac MRI in children with multisystem inflammatory syndrome associated with COVID-19. Radiology 297, E283\u2013E288 (2020).","journal-title":"Radiology"},{"key":"709_CR226","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.echo.2020.07.019","volume":"33","author":"M Gaitonde","year":"2020","unstructured":"Gaitonde, M. et al. COVID-19-related multisystem inflammatory syndrome in children affects left ventricular function and global strain compared with Kawasaki disease. J. Am. Soc. Echocardiogr. 33, 1285\u20131287 (2020).","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"709_CR227","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jpeds.2020.08.002","volume":"228","author":"S Jhaveri","year":"2020","unstructured":"Jhaveri, S. et al. Longitudinal echocardiographic assessment of coronary arteries and left ventricular function following multisystem inflammatory syndrome in children. J. Pediatr. 228, 290\u2013293 (2020).","journal-title":"J. Pediatr."},{"key":"709_CR228","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/ped.13614","volume":"60","author":"LB Gamez-Gonzalez","year":"2018","unstructured":"Gamez-Gonzalez, L. B. et al. Kawasaki disease shock syndrome: unique and severe subtype of Kawasaki disease. Pediatr. Int. 60, 781\u2013790 (2018).","journal-title":"Pediatr. Int."},{"key":"709_CR229","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1017\/S1047951105001344","volume":"15","author":"E Tsuda","year":"2005","unstructured":"Tsuda, E. et al. Changes in causes of sudden deaths by decade in patients with coronary arterial lesions due to Kawasaki disease. Cardiol. Young. 15, 481\u2013488 (2005).","journal-title":"Cardiol. Young."},{"key":"709_CR230","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s00134-012-2473-8","volume":"38","author":"P Gatterre","year":"2012","unstructured":"Gatterre, P. et al. Kawasaki disease: an unexpected etiology of shock and multiple organ dysfunction syndrome. Intensive Care Med. 38, 872\u2013878 (2012).","journal-title":"Intensive Care Med."},{"key":"709_CR231","doi-asserted-by":"crossref","first-page":"e783","DOI":"10.1542\/peds.2008-1871","volume":"123","author":"JT Kanegaye","year":"2009","unstructured":"Kanegaye, J. T. et al. Recognition of a Kawasaki disease shock syndrome. Pediatrics 123, e783\u2013e789 (2009).","journal-title":"Pediatrics"},{"key":"709_CR232","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12969-018-0303-4","volume":"17","author":"Y Li","year":"2019","unstructured":"Li, Y. et al. Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-\u03b3 as biomarkers for early recognition. Pediatr. Rheumatol. 17, 1 (2019).","journal-title":"Pediatr. Rheumatol."},{"key":"709_CR233","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1177\/0009922817729483","volume":"57","author":"L Ma","year":"2018","unstructured":"Ma, L., Zhang, Y.-Y. & Yu, H.-G. Clinical manifestations of Kawasaki disease shock syndrome. Clin. Pediatr. 57, 428\u2013435 (2018).","journal-title":"Clin. Pediatr."},{"key":"709_CR234","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1161\/CIRCULATIONAHA.120.049836","volume":"143","author":"T Alsaied","year":"2021","unstructured":"Alsaied, T. et al. Review of cardiac involvement in multisystem inflammatory syndrome in children. Circulation 143, 78\u201388 (2021).","journal-title":"Circulation"},{"key":"709_CR235","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/CIRCULATIONAHA.120.050065","volume":"143","author":"I Valverde","year":"2021","unstructured":"Valverde, I. et al. Acute cardiovascular manifestations in 286 children with multisystem inflammatory syndrome associated with COVID-19 infection in Europe. Circulation 143, 21\u201332 (2021).","journal-title":"Circulation"},{"key":"709_CR236","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s10875-020-00941-0","volume":"41","author":"J Toubiana","year":"2021","unstructured":"Toubiana, J. et al. Distinctive features of Kawasaki disease following SARS-CoV-2 infection: a controlled study in Paris, France. J. Clin. Immunol. 41, 526\u2013535 (2021).","journal-title":"J. Clin. Immunol."},{"key":"709_CR237","doi-asserted-by":"crossref","first-page":"625456","DOI":"10.3389\/fped.2021.625456","volume":"9","author":"J Suzuki","year":"2021","unstructured":"Suzuki, J. et al. Kawasaki disease shock syndrome in Japan and comparison with multisystem inflammatory syndrome in children in European countries. Front. Pediatr. 9, 625456 (2021).","journal-title":"Front. Pediatr."},{"key":"709_CR238","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/s004310050893","volume":"157","author":"K Kaneko","year":"1998","unstructured":"Kaneko, K., Takahashi, K., Fujiwara, S., Maruyama, T. & Obinata, K. Kawasaki disease followed by haemophagocytic syndrome. Eur. J. Pediatr. 157, 610\u2013611 (1998).","journal-title":"Eur. J. Pediatr."},{"key":"709_CR239","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1097\/INF.0b013e31817ecb6d","volume":"27","author":"C Cummings","year":"2008","unstructured":"Cummings, C., McCarthy, P., van Hoff, J. & Porter, G. Kawasaki disease associated with reactive hemophagocytic lymphohistiocytosis. Pediatr. Infect. Dis. J. 27, 1116\u20131118 (2008).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"709_CR240","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/MPH.0b013e3181dccbf4","volume":"32","author":"GA Latino","year":"2010","unstructured":"Latino, G. A., Manlhiot, C., Yeung, R. S. M., Chahal, N. & McCrindle, B. W. Macrophage activation syndrome in the acute phase of Kawasaki disease. J. Pediatr. Hematol. Oncol. 32, 527\u2013531 (2010).","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"709_CR241","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3899\/jrheum.200361","volume":"48","author":"V Natoli","year":"2021","unstructured":"Natoli, V., Rosina, S. & Ravelli, A. Is macrophage activation syndrome in Kawasaki disease underrecognized? J. Rheumatol. 48, 162\u2013164 (2021).","journal-title":"J. Rheumatol."},{"key":"709_CR242","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cyto.2019.03.001","volume":"119","author":"A Jinkawa","year":"2019","unstructured":"Jinkawa, A. et al. Cytokine profile of macrophage activation syndrome associated with Kawasaki disease. Cytokine 119, 52\u201356 (2019).","journal-title":"Cytokine"},{"key":"709_CR243","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/1756-185X.14078","volume":"24","author":"F Ayd\u0131n","year":"2021","unstructured":"Ayd\u0131n, F. et al. Comparison of baseline laboratory findings of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis and multisystem inflammatory syndrome in children. Int. J. Rheum. Dis. 24, 542\u2013547 (2021).","journal-title":"Int. J. Rheum. Dis."},{"key":"709_CR244","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1067\/mpd.2003.232","volume":"142","author":"F Zulian","year":"2003","unstructured":"Zulian, F. et al. Acute surgical abdomen as presenting manifestation of Kawasaki disease. J. Pediatr. 142, 731\u2013735 (2003).","journal-title":"J. Pediatr."},{"key":"709_CR245","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/BF02396613","volume":"17","author":"T Miyake","year":"1987","unstructured":"Miyake, T. et al. Small bowel pseudo-obstruction in Kawasaki disease. Pediatr. Radiol. 17, 383\u2013386 (1987).","journal-title":"Pediatr. Radiol."},{"key":"709_CR246","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.adaj.2020.11.014","volume":"152","author":"S Halepas","year":"2021","unstructured":"Halepas, S. et al. Oral manifestations of COVID-2019-related multisystem inflammatory syndrome in children: a review of 47 pediatric patients. J. Am. Dent. Assoc. 152, 202\u2013208 (2021).","journal-title":"J. Am. Dent. Assoc."},{"key":"709_CR247","first-page":"365","volume":"91","author":"A Saguil","year":"2015","unstructured":"Saguil, A., Fargo, M. & Grogan, S. Diagnosis and management of Kawasaki disease. Am. Fam. Physician 91, 365\u2013371 (2015).","journal-title":"Am. Fam. Physician"},{"key":"709_CR248","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1053\/j.gastro.2020.06.084","volume":"160","author":"T-H Chen","year":"2020","unstructured":"Chen, T.-H., Kao, W.-T. & Tseng, Y.-H. Gastrointestinal involvements in children with COVID-related multisystem inflammatory syndrome. Gastroenterology 160, 1887\u20131888 (2020).","journal-title":"Gastroenterology"},{"key":"709_CR249","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1001\/jamaneurol.2021.0504","volume":"78","author":"KL LaRovere","year":"2021","unstructured":"LaRovere, K. L. et al. Neurologic involvement in children and adolescents hospitalized in the United States for COVID-19 or multisystem inflammatory syndrome. JAMA Neurol. 78, 536\u2013547 (2021).","journal-title":"JAMA Neurol."},{"key":"709_CR250","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/00006454-199806000-00008","volume":"17","author":"LD Dengler","year":"1998","unstructured":"Dengler, L. D. et al. Cerebrospinal fluid profile in patients with acute Kawasaki disease. Pediatr. Infect. Dis. J. 17, 478\u2013481 (1998).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"709_CR251","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12969-020-00452-7","volume":"18","author":"X Liu","year":"2020","unstructured":"Liu, X. et al. Neurological involvement in Kawasaki disease: a retrospective study. Pediatr. Rheumatol. Online J. 18, 61 (2020).","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"709_CR252","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jmii.2016.06.004","volume":"51","author":"C-C Kuo","year":"2018","unstructured":"Kuo, C.-C. et al. Characteristics of children with Kawasaki disease requiring intensive care: 10 years\u2019 experience at a tertiary pediatric hospital. J. Microbiol. Immunol. Infect. 51, 184\u2013190 (2018).","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"709_CR253","first-page":"51","volume":"38","author":"T Radia","year":"2020","unstructured":"Radia, T. et al. Multi-system inflammatory syndrome in children & adolescents (MIS-C): a systematic review of clinical features and presentation. Paediatr. Respir. Rev. 38, 51\u201357 (2020).","journal-title":"Paediatr. Respir. Rev."},{"key":"709_CR254","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S2352-4642(21)00050-X","volume":"5","author":"JY Abrams","year":"2021","unstructured":"Abrams, J. Y. et al. Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study. Lancet Child. Adolesc. Health 5, 323\u2013331 (2021).","journal-title":"Lancet Child. Adolesc. Health"},{"key":"709_CR255","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2020-023432","volume":"147","author":"N Ouldali","year":"2021","unstructured":"Ouldali, N. et al. Factors associated with severe SARS-CoV-2 infection. Pediatrics 147, e2020023432 (2021).","journal-title":"Pediatrics"},{"key":"709_CR256","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","volume":"80","author":"Q Ye","year":"2020","unstructured":"Ye, Q., Wang, B. & Mao, J. The pathogenesis and treatment of the \u2018cytokine storm\u2019 in COVID-19. J. Infect. 80, 607\u2013613 (2020).","journal-title":"J. Infect."},{"key":"709_CR257","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/MPG.0000000000002809","volume":"71","author":"MT Dolinger","year":"2020","unstructured":"Dolinger, M. T. et al. Pediatric Crohn disease and multisystem inflammatory syndrome in children (MIS-C) and COVID-19 treated with infliximab. J. Pediatr. Gastroenterol. Nutr. 71, 153\u2013155 (2020).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"709_CR258","doi-asserted-by":"crossref","DOI":"10.1172\/JCI144554","volume":"131","author":"A Esteve-Sole","year":"2021","unstructured":"Esteve-Sole, A. et al. Similarities and differences between the immunopathogenesis of COVID-19-related pediatric multisystem inflammatory syndrome and Kawasaki disease. J. Clin. Invest. 131, e144554 (2021). A comparative analysis of circulating cytokines and chemokines to have an insight on the similarities and differences between MIS-C and Kawasaki disease.","journal-title":"J. Clin. Invest."},{"key":"709_CR259","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1111\/jth.15340","volume":"19","author":"M Al-Ghafry","year":"2021","unstructured":"Al-Ghafry, M. et al. Multisystem inflammatory syndrome in children (MIS-C) and the prothrombotic state: coagulation profiles and rotational thromboelastometry in a MIS-C cohort. J. Thromb. Haemost. 19, 1764\u20131770 (2021).","journal-title":"J. Thromb. Haemost."},{"key":"709_CR260","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1038\/s41591-020-1140-9","volume":"26","author":"OM Martinez","year":"2020","unstructured":"Martinez, O. M., Bridges, N. D., Goldmuntz, E. & Pascual, V. The immune roadmap for understanding multi-system inflammatory syndrome in children: opportunities and challenges. Nat. Med. 26, 1819\u20131824 (2020).","journal-title":"Nat. Med."},{"key":"709_CR261","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.5005\/jp-journals-10071-23658","volume":"24","author":"L Shobhavat","year":"2020","unstructured":"Shobhavat, L. et al. Multisystem inflammatory syndrome in children: clinical features and management-intensive care experience from a pediatric public hospital in western India. Indian. J. Crit. Care Med. Peer Rev. 24, 1089\u20131094 (2020).","journal-title":"Indian. J. Crit. Care Med. Peer Rev."},{"key":"709_CR262","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.3201\/eid2705.204591","volume":"27","author":"C Ni\u00f1o-Taravilla","year":"2021","unstructured":"Ni\u00f1o-Taravilla, C., Otaola-Arca, H., Lara-Aguilera, N., Zuleta-Morales, Y. & Ortiz-Fritz, P. Multisystem inflammatory syndrome in children, Chile, May-August 2020. Emerg. Infect. Dis. 27, 1457\u20131461 (2021).","journal-title":"Emerg. Infect. Dis."},{"key":"709_CR263","doi-asserted-by":"crossref","first-page":"fmab050","DOI":"10.1093\/tropej\/fmab050","volume":"67","author":"O Tolunay","year":"2021","unstructured":"Tolunay, O. et al. Multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19: a case series experience in a tertiary care hospital of southern Turkey. J. Trop. Pediatr. 67, fmab050 (2021).","journal-title":"J. Trop. Pediatr."},{"key":"709_CR264","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1001\/jamadermatol.2020.4779","volume":"157","author":"TK Young","year":"2021","unstructured":"Young, T. K. et al. Mucocutaneous manifestations of multisystem inflammatory syndrome in children during the COVID-19 pandemic. JAMA Dermatol. 157, 207\u2013212 (2021).","journal-title":"JAMA Dermatol."},{"key":"709_CR265","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1161\/01.CIR.0000145143.19711.78","volume":"110","author":"W Newburger Jane","year":"2004","unstructured":"Newburger Jane, W. et al. Diagnosis, treatment, and long-term management of Kawasaki disease. Circulation 110, 2747\u20132771 (2004).","journal-title":"Circulation"},{"key":"709_CR266","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/tropej\/fmp110","volume":"56","author":"H Ozdemir","year":"2010","unstructured":"Ozdemir, H. et al. Clinical and epidemiological characteristics of children with Kawasaki disease in Turkey. J. Trop. Pediatr. 56, 260\u2013262 (2010).","journal-title":"J. Trop. Pediatr."},{"key":"709_CR267","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1651-2227.1994.tb12985.x","volume":"83","author":"J Fukushige","year":"1994","unstructured":"Fukushige, J., Takahashi, N., Ueda, Y. & Ueda, K. Incidence and clinical features of incomplete Kawasaki disease. Acta Paediatr. Oslo. Nor. 83, 1057\u20131060 (1994).","journal-title":"Acta Paediatr. Oslo. Nor."},{"key":"709_CR268","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/01.inf.0000215263.96289.1c","volume":"25","author":"RYT Sung","year":"2006","unstructured":"Sung, R. Y. T. et al. Lack of association of cervical lymphadenopathy and coronary artery complications in Kawasaki disease. Pediatr. Infect. Dis. J. 25, 521\u2013525 (2006).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"709_CR269","first-page":"116","volume":"8","author":"LB Smith","year":"1989","unstructured":"Smith, L. B., Newburger, J. W. & Burns, J. C. Kawasaki syndrome and the eye. Pediatr. Infect. Dis. J. 8, 116\u2013118 (1989).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"709_CR270","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jpeds.2008.10.006","volume":"154","author":"AL Baker","year":"2009","unstructured":"Baker, A. L. et al. Associated symptoms in the ten days before diagnosis of Kawasaki disease. J. Pediatr. 154, 592\u2013595.e2 (2009).","journal-title":"J. Pediatr."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41584-021-00709-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-021-00709-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-021-00709-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T01:19:13Z","timestamp":1726017553000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41584-021-00709-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,29]]},"references-count":270,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["709"],"URL":"https:\/\/doi.org\/10.1038\/s41584-021-00709-9","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,29]]},"assertion":[{"value":"4 October 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}